Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Steam Quality Testing: Dryness, Superheat and Non-Condensable Gases

Posted on November 23, 2025November 22, 2025 By digi


Steam Quality Testing: Dryness, Superheat and Non-Condensable Gases

Comprehensive Step-by-Step Guide to Steam Quality Testing: Dryness, Superheat and Non-Condensable Gases in Pharma GMP Utilities

Steam quality testing is an essential element within pharmaceutical manufacturing, particularly concerning the assurance of sterility assurance via utilities such as clean steam. Controlling steam quality parameters including dryness fraction, superheat, and the presence of non-condensable gases directly influences the integrity of sterilization processes, microbial control, and ultimately patient safety. This article provides a detailed step-by-step tutorial to assess steam quality in compliance with global GMP regulations, focusing on pharma manufacturing environments in the US, UK, and EU.

Introduction to Steam Quality and Its Relevance to Pharma Microbiology and Sterility Assurance

In pharmaceutical manufacturing, steam serves

as a critical utility for sterilization of equipment, production lines, and pharmaceutical water system components such as PW (Purified Water) and WFI (Water for Injection) distribution loops. Steam must meet stringent quality requirements to prevent contamination risks including microbial bioburden and endotoxin transfer. The primary steam quality parameters are:

  • Dryness fraction: The ratio of vapor to liquid water in steam
  • Superheat: The temperature rise above saturation temperature at a given pressure
  • Non-condensable gases (NCGs): Gases such as oxygen, nitrogen, or carbon dioxide dissolved or mixed within steam

All three parameters affect steam’s efficiency and safety for sterilization. Excess moisture (low dryness) can introduce microbial contamination or endotoxins. Superheated steam reduces sterilization efficacy since lack of latent heat transfer impairs microbial kill mechanisms. Meanwhile, NCGs create a thermal barrier around sterilized surfaces, leading to inadequate process lethality. Regulatory bodies such as the FDA and EMA require validation and ongoing monitoring of steam quality as part of pharmaceutical GMP utilities to maintain sterility assurance.

Understanding the chemistry and physics behind steam parameters is vital for pharmaceutical microbiologists, QA/QC personnel, and clinical manufacturing professionals who define and uphold environmental monitoring and cleaning validation strategies.

Step 1: Planning and Preparation for Steam Quality Testing

Before initiating steam quality testing, appropriate planning and procedural documentation are required to align with GMP standards such as FDA 21 CFR Part 211 and ICH Q7 guidelines. Key preparatory steps include:

1.1 Define Test Objectives and Acceptance Criteria

The first step is to explicitly define what steam quality parameters will be measured and to establish acceptance criteria based on pharmacopoeial standards (e.g., European Pharmacopoeia, USP) and internal quality standards. For example:

  • Dryness fraction ≥ 0.97 (≥97% vapor phase)
  • Superheat ≤ 10 °C above saturated steam temperature at test pressure
  • Non-condensable gases ≤ 3% by volume
Also Read:  How to Align GMP Compliance with Global Drug Development Regulations

1.2 Identify Testing Frequency and Sampling Points

Decide on routine versus qualification testing schedules. Steam quality should be tested:

  • Post-installation and during qualification stages of clean steam generation and distribution systems.
  • At regular intervals during routine monitoring as defined in the Quality Management System (QMS).

Sampling points include autoclave steam inlets, steam distribution headers, and points near the interface with critical equipment such as sterilizers and water systems.

1.3 Prepare Required Equipment and Reference Materials

Ensure availability of calibrated instruments and consumables:

  • Dryness testing apparatus (e.g., throttling calorimeter, Brearley tube setup)
  • Superheat temperature sensors (thermocouples or RTDs with appropriate accuracy)
  • Gas extraction and analysis equipment for non-condensable gases, e.g., gas chromatograph or portable NCG analyzers
  • Documentation templates and electronic or paper batch records compliant with GMP guidelines

Equipment calibration should align with regulatory expectations. For instance, the lab thermometer or thermocouples must have traceability and certificates.

Step 2: Measuring Dryness Fraction of Steam

The dryness fraction represents the portion of steam consisting of vapor rather than liquid water and is crucial for verifying that steam is ‘dry’ enough to be suitable for sterilization applications without compromising pharma microbiology control. The procedural steps for testing dryness fraction are outlined below.

2.1 Understanding Dryness Fraction Measurement Principles

Dryness fraction is determined by indirect methods such as the calorimetric or throttling calorimetry methods. The common principle is to cause steam to undergo a controlled pressure drop or expansion and measure temperature changes, enabling calculation of moisture content.

2.2 Step-by-Step Approach for Dryness Fraction Testing Using a Brearley Tube

  • Connect the Brearley Tube to the steam supply line at the defined sampling point ensuring proper isolation valves are installed and opened appropriately.
  • Allow steam to flow through the apparatus until a stable temperature reading is obtained.
  • Record temperatures at the inlet (T1) and outlet (T2) of the tube as accurately as possible using calibrated thermocouples.
  • Calculate dryness fraction (x) using the enthalpy formulas based on temperature data and steam tables. The formula generally involves the enthalpy of steam at the two points and latent heat.
  • Compare calculated dryness fraction to predefined acceptance criteria, typically ≥0.97.

2.3 Important Considerations and Common Pitfalls

Ensure that:

  • Steam pressure remains stable during the test, as pressure fluctuations affect temperature and enthalpy values.
  • The sampling point is representative and free from water accumulation.
  • Calibrated instrumentation and adequate operator training are maintained to reduce variability.
Also Read:  The Importance of a Robust QMS in Supporting TQM for GMP Compliance

Failure to maintain steam dryness can lead to increased bioburden risks especially when used for sterilizing GMP utilities such as PW and WFI systems, impacting environmental monitoring strategies and potentially affecting endotoxin levels.

Step 3: Assessing Superheat in Steam Systems

Superheat evaluation is critical since steam that is superheated beyond saturation temperature is less effective at transferring heat for sterilization, compromising microbial inactivation. The process for testing superheat involves precise temperature measurement and calculations relative to steam pressure.

3.1 Understanding Superheat and Its Impact on Sterility Assurance

Superheated steam is steam heated above its saturation temperature at a given pressure, resulting in lower latent heat availability. This reduces condensate formation on surfaces, critical for instant heat transfer during sterilization cycles. Excessive superheat (>10 °C) can prolong sterilization times or lead to incomplete sterilization, challenging GMP compliance.

3.2 Stepwise Measurement Procedure

  • Install temperature sensors (thermocouples or RTDs) at the steam sampling point and ensure calibration traceability.
  • Measure the operating steam pressure accurately at the same sampling location.
  • Consult steam saturation temperature tables to find saturation temperature corresponding to measured pressure.
  • Record the actual steam temperature from sensors.
  • Calculate superheat by subtracting the saturation temperature from the actual temperature.
  • Compare superheat value against acceptance criteria (typically ≤10 °C for clean steam in sterilization).

3.3 Mitigation Actions for Excessive Superheat

If superheat exceeds acceptable levels:

  • Inspect steam traps, pressure regulators, and moisture separators as these upstream components influence steam thermodynamic state.
  • Validate the clean steam generator and ensure proper maintenance aligned with manufacturer guidance and GMP utilities protocols.
  • Document findings and corrective actions within the CAPA (Corrective and Preventive Action) framework.

Step 4: Testing for Non-Condensable Gases (NCGs) Presence

Non-condensable gases such as oxygen and nitrogen interfere with steam sterilization by creating insulating pockets, leading to bioburden survival and incomplete heat penetration. Detecting and quantifying NCGs is therefore vital for effective sterility assurance and microbiological risk management.

4.1 Principle of Non-Condensable Gases Testing

Steam is passed through an analyzer that separates the gaseous constituents and quantifies the volume or concentration of NCGs present. Acceptable thresholds are generally <3% by volume, but specific limits depend on internal specifications and regulatory standards.

4.2 Stepwise Procedure for NCG Testing

  • Collect steam sample from the clean steam line using a gas-tight sampling system under representative operating conditions.
  • Pass steam through a condenser or chilled trap to condense steam vapor, leaving behind non-condensable gases.
  • Analyse residual gases using an appropriate detector such as a gas chromatograph or portable NCG analyzer to quantify.
  • Record and document results carefully including environmental conditions and sampling time.
  • Verify results against acceptance criteria and initiate investigations if NCG presence exceeds limits.

4.3 Addressing Elevated NCG Levels

  • Inspect air vents, steam traps, and condensate return lines for leaks or blockages.
  • Ensure steam generator integrity and proper venting of air pockets at startup or after maintenance.
  • Review environmental monitoring data and bioburden trends to detect possible sanitary failures.
Also Read:  Microbial Contamination in Stability Chambers: Prevention and Response

Step 5: Documentation, Trending and Compliance Strategies

Comprehensive documentation is a regulatory requirement and facilitates continuous improvement of steam quality and overall sterility assurance. Proper record management enhances readiness for inspections by authorities such as the FDA, MHRA, and EMA.

5.1 Documenting Steam Quality Testing Results

All test results must be collated in controlled documentation aligned with current GMP standards:

  • Batch records or environmental monitoring reports capturing date, time, sample location, tester identity, instrument identification, and calibration status.
  • Deviation reports if test results fall outside predetermined limits.
  • CAPAs or investigation files detailing root cause analysis and corrective action plans.

5.2 Trending and Periodic Review

Data from routine steam quality testing should be trended and analyzed to detect early signals of system degradation or drift in utility performance:

  • Use statistical process control tools to monitor dryness fraction, superheat, and NCG data over time.
  • Correlate steam quality trends with environmental monitoring and microbiological test outcomes such as endotoxin test results.
  • Support periodic review of supplier qualification if outsourced clean steam generators or systems are used.

5.3 Compliance and Regulatory Alignment

Steam quality testing and utility control form a pivotal part of WHO GMP guidelines for utilities as well as Annex 15 of the EU GMP, requiring documented evidence of qualification and maintenance. Pharmaceutical companies should ensure their SOPs explicitly define steam quality parameters and that these are integrated into the overall pharmaceutical quality system (PQS).

Engage regulatory experts and auditors to review steam quality protocols periodically and update testing methodologies based on technological advancements and inspection feedback.

Conclusion and Best Practices for Sustainable Steam Quality Management

Pharmaceutical manufacturers operating in the US, UK, and EU regulatory environments must rigorously test and monitor steam quality using validated methods to uphold sterility assurance and minimize risks associated with pharma microbiology. A systematic approach covering dryness fraction, superheat, and non-condensable gases — combined with robust documentation, trending, and corrective action procedures — ensures compliance and product safety.

Key best-practice recommendations include:

  • Integrating steam quality criteria into qualification protocols for sterilizers and GMP utilities.
  • Training operational staff and microbiologists in understanding steam thermodynamics and testing methods.
  • Regularly calibrating and maintaining testing equipment to reduce variability and false results.
  • Following risk-based approaches aligned with ICH Q9 Quality Risk Management principles to prioritize monitoring efforts.
  • Incorporating steam quality data into broader pharmaceutical water systems validation and maintenance programs.

With these practices, pharmaceutical facilities can confidently sustain microbial control, ensure endotoxin minimization, and maintain compliance with evolving regulatory expectations related to clean steam and GMP utilities.

Sterility, Microbiology & Utilities Tags:clean steam, Environmental monitoring, GMP compliance, pharma microbiology, PW, sterility assurance, water systems, WFI

Post navigation

Previous Post: Use of Clean Steam in Sterilization, CIP and Aseptic Support Systems
Next Post: Clean Steam Systems: Design, Qualification and Routine Monitoring

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme